Evidence map›Paper›PMID 37118222›Full record

ArticleAttention, perception & psychophysics2023

Feature-blind attentional suppression of salient distractors.

Xiaojin Ma, Richard A Abrams

Abstract read
PubMed Publisher
In one paragraph

Article in Attention, perception & psychophysics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Signal suppression makes search less effortful.Cognitive, affective & behavioral neuroscience · 2026
    Article
  4. Avoidance of capture by motion onset.Attention, perception & psychophysics · 2026
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaojin MaDepartment of Psychological & Brain Sciences, Washington University in St. Louis, St. Louis, MO, USA. xiaojinma@wustl.edu.ORCID http://orcid.org/0000-0003-4592-6408
Richard A AbramsDepartment of Psychological & Brain Sciences, Washington University in St. Louis, St. Louis, MO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recent paper has reported, for the first time, that people are capable of suppressing salient singleton distractors of unknown color if the search task requires them to search for the most prevalent of several shapes in the display. We identify here several potential limitations of the earlier findings. In particular, in the reported experiments, the likelihood of a salient distractor was higher than what is typically studied, the distractor object was similar in shape to the relevant objects, only two colors were studied, the distractor was consistently a fixed shape, and the distractor was always a unique shape different from the search targets. Each of these limitations leaves open some questions about the generality of the findings. We address each of the concerns here, and show, in five experiments, that the ability to suppress distractors of unknown color is a robust finding that is not compromised by the potential limitations identified. When searching for the most prevalent of several shapes in a display, people can indeed suppress capture by otherwise-salient color singleton distractors even when their color is not known in advance (i.e., in a feature-blind manner), facilitating efficient search. The experiments confirm the ability to suppress visual elements based on second-order (e.g., a unique color) or global salience information, and not merely based on first-order (e.g., a specific color) information.

Indexed as

AttentionHumansProbabilityReaction TimeAttentional captureSuppressionVisual attentionVisual search

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.